Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus

Lupus

Volumn 23, Issue 7, 2014, Pages 635-642

  Yokoyama, T ^a   Fujii, T ^a,b   Kondo Ishikawa, S ^a   Yamakawa, N ^a   Nakano, M ^a   Yukawa, N ^a   Yoshifuji, H ^a   Ohmura, K ^a   Mimori, T ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti U1RNP antibodies; Cerebrospinal fluid; IFN ; MCP 1; Neuropsychiatric systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; ANTI U1 RIBONUCLEOPROTEIN ANTIBODY; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RIBONUCLEOPROTEIN ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ADULT; ANALYTIC METHOD; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLEX CYTOKINE ANALYSIS; NEUROPSYCHIATRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; AGED; BLOOD; BRAIN VASCULITIS; CHILD; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHILD; FEMALE; HUMANS; INFLAMMATION; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; YOUNG ADULT;

EID: 84903647169     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314522337     Document Type: Article

References (28)

1. Bertsias GK, Boumpas DT. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol 2010; 6: 358-367.
2. Hanly JG, Urowitz MB, Su L, et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis 2011; 70: 1726-1732.
3. Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A, et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 2008; 3: e3347.
4. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7: 1189-1193.
5. Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2008; 58: 1130-1135.
6. Okada J, Hamana T, Kondo H. Anti-U1RNP antibody and aseptic meningitis in connective tissue diseases. Scand J Rheumatol 2003; 32: 247-252.
7. Sato T, Fujii T, Yokoyama T, et al. Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum 2010; 62: 3730-3740.
8. Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 2000; 9: 498-503.
9. Lu XY, Zhu CQ, Qian J, Chen XX, Ye S, Gu YY. Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection. Lupus 2010; 19: 689-695.
10. Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T. Interferonalpha in lupus psychosis. Arthritis Rheum 1992; 35: 417-422.
11. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A, et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1242-1250.
12. Okamoto H, Katsumata Y, Nishimura K, Kamatani N. Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus. Arthritis Rheum 2004; 50: 3731-3732.
13. Iikuni N, Okamoto H, Yoshio T, et al. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus. Ann Rheum Dis 2006; 65: 253-256.
14. Sato E, Iikuni N, Yoshio T, Minota S, Kamatani N, Okamoto H. Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus. Ann Rheum Dis 2006; 65: 1257-1259.
15. Eloranta ML, Lövgren T, Finke D, et al. Regulation of the interferon- alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum 2009; 60: 2418-2427.
16. Savarese E, Chae OW, Trowitzsch S, et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 2006; 107: 3229-3234.
17. Santer DM, Yoshio T, Minota S, Möller T, Elkon KB. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol 2009; 182: 1192-1201.
18. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
19. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
20. Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature ACR. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
21. Yoshifuji H, Fujii T, Kobayashi S, et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006; 39: 233-241.
22. Fu Q, Chen X, Cui H, et al. Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients. Arthritis Res Ther 2008; 10: R112.
23. Fragoso-Loyo H, Atisha-Fregoso Y, Núñez-Alvarez CA, Llorente L, Sánchez-Guerrero J. Utility of interferon-alpha as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus. J Rheumatol 2012; 39: 504-509.
24. Båve U, Magnusson M, Eloranta ML, Perers A, Alm GV, Rönnblom L. Fc gamma RIIa is expressed on natural IFNalpha- producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J Immunol 2003; 171: 3296-3302.
25. Fujita Y, Fujii T, Nakashima R, Tanaka M, Mimori T. Aseptic meningitis in mixed connective tissue disease: Cytokine and anti- U1RNP antibodies in cerebrospinal fluids from two different cases. Mod Rheumatol 2008; 18: 184-188.
26. Herbst F, Artlich A, Neuhäuser G, Gortner L, Diehl M, Risse J. MCTD in the differential diagnosis of cerebellar ataxia [article in German]. Klin Padiatr 2001; 213: 332-333.
27. Mimori T. Autoantibodies in connective tissue diseases: Clinical significance and analysis of target autoantigens. Intern Med 1999; 38: 523-532.
28. Sato S, Kawashima H, Hoshika A, Yoshio T. Clinical analysis of anti-NR2 glutamate receptor antibodies and interleukin-6 with neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford) 2011; 50: 2142-2144.